CSIMarket
 



Johnson and Johnson  (JNJ)
Other Ticker:  
 
 


Johnson and Johnson Segments

 
PROCRIT
   3.06 % of total Revenue
RISPERDAL
   2.82 % of total Revenue
REMICADE
   18.37 % of total Revenue
VELCADE
   3.84 % of total Revenue
CONCERTA
   2.42 % of total Revenue
INVEGA
   1.8 % of total Revenue
Other
   9.08 % of total Revenue
Total Pharmaceutical
   44.67 % of total Revenue
Med. Dev. & Diag.
   35.75 % of total Revenue
Nutritionals
   5.48 % of total Revenue
Skin Care
   5.03 % of total Revenue
Total Consumer
   19.58 % of total Revenue
 

Business Segments (Sep. 30, 2015)
Revenues
(in millions $)
III. Quarter
%
(of total Revenues)
(Sep. 30, 2015)
Income
(in millions $)
III. Quarter
%
(Profit Margin)
PROCRIT
545.00 3.06 % 0.00 -
RISPERDAL
501.00 2.82 % 0.00 -
REMICADE
3,268.00 18.37 % 0.00 -
VELCADE
683.00 3.84 % 0.00 -
CONCERTA
430.00 2.42 % 0.00 -
INVEGA
321.00 1.8 % 0.00 -
Other
1,615.00 9.08 % 0.00 -
Total Pharmaceutical
7,946.00 44.67 % 4,543.00 57.17 %
Med. Dev. & Diag.
6,358.00 35.75 % 3,013.00 47.39 %
Nutritionals
974.00 5.48 % 0.00 -
Skin Care
894.00 5.03 % 0.00 -
Total Consumer
3,483.00 19.58 % 1,355.00 38.9 %
Total
17,787.00 100 % 8,911.00 50.1 %

• View Income Statement • View Competition by Segment • View Annual Report

Growth rates by Segment (Sep. 30, 2015)
Y/Y Revenue
%
III. Quarter
Q/Q Revenue
%
(Sep. 30, 2015)
Y/Y Income
%
III. Quarter
Q/Q Income
%
PROCRIT
77.52 % 97.46 % - -
RISPERDAL
76.41 % 102.83 % - -
REMICADE
83.39 % 95.92 % - -
VELCADE
75.58 % 98.55 % - -
CONCERTA
218.52 % 108.74 % - -
INVEGA
105.77 % 93.37 % - -
Other
-2.12 % 0 % - -
Total Pharmaceutical
-4.35 % 0 % 39.91 % 10.21 %
Med. Dev. & Diag.
-3.24 % 0 % -11.36 % 90.21 %
Nutritionals
-4.42 % 0 % - -
Skin Care
-2.83 % 0 % - -
Total Consumer
-2.95 % 0 % 232.92 % 327.44 %
Total
-3.68 % 0 % 26.34 % 47.95 %

• View Growth rates • View Competitors Segment Growth • View Market Share

To get more information on Johnson And Johnson's PROCRIT, RISPERDAL, REMICADE, VELCADE, CONCERTA, INVEGA, Other, Total Pharmaceutical, Med. Dev. & Diag., Nutritionals, Skin Care, Total Consumer, Total segment. Select each division with the arrow.

  Johnson And Johnson's

Business Segments Description



SEGMENTS OF BUSINESS

Johnson & Johnson's worldwide business is divided into three segments:

Consumer, Pharmaceutical and Medical Devices and Diagnostics.

CONSUMER

The Consumer segment manufactures and markets a broad range of products used in the baby and child care, skin care, oral and wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. Major brands include AVEENO skin care products; BAND-AID Brand Adhesive Bandages; CAREFREE Panty Shields; CLEAN & CLEAR teen skin care products; JOHNSON'S Baby line of products; MOTRIN IB ibuprofen products; PEPCID AC Acid Controller from Johnson & Johnson -- Merck Consumer Pharmaceuticals Co.; NEUTROGENA skin and hair care products; SPLENDA, a no calorie sweetener; STAYFREE sanitary protection products; and the broad family of TYLENOL acetaminophen products. These products are marketed principally to the general public and sold both to wholesalers and directly to independent and chain retail outlets throughout the world.

PHARMACEUTICAL

The Pharmaceutical segment includes products in the following therapeutic areas: anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use. Key products in the Pharmaceutical segment include: REMICADE® (infliximab), a biologic approved for the treatment of a number of immune mediated inflammatory diseases; PROCRIT® (Epoetin alfa, sold outside the U.S. as EPREX®), a biotechnology-derived product that stimulates red blood cell production; LEVAQUIN® (levofloxacin) in the anti-infective field; RISPERDAL® CONSTA® (risperidone), a long-acting injectable for the treatment of schizophrenia; CONCERTA® (methylphenidate HCl), a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX®/PARIET®, a proton pump inhibitor co-marketed with Eisai Inc.; DURAGESIC®/Fentanyl Transdermal (fentanyl transdermal system, sold outside the U.S. as DUROGESIC®), a treatment for chronic pain that offers a novel delivery system; VELCADE® (bortezomib), a product for the treatment for multiple myeloma; PREZISTA® (darunavir) for the treatment of HIV/AIDS patients; and INVEGA® (paliperidone), a once-daily atypical antipsychotic.


MEDICAL DEVICES AND DIAGNOSTICS

The Medical Devices and Diagnostics segment includes a broad range of products used by or under the direction of physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. These products include Ethicon's wound care and women's health products; Ethicon Endo-Surgery's minimally invasive surgical products; Cordis' circulatory disease management products; LifeScan's blood glucose monitoring products; Ortho-Clinical Diagnostics' professional diagnostic products; DePuy's orthopaedic joint reconstruction and spinal products and Vistakon's disposable contact lenses. Distribution to these health care professional markets is done both directly and through surgical supply and other dealers.

   

Sales by Geography Competition By Business Segments Company Profile
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VRDR's Profile

Stock Price

VRDR's Financials

Business Description

Fundamentals

Charts & Quotes

VRDR's News

Suppliers

VRDR's Competitors

Customers & Markets

Economic Indicators

VRDR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071